Other studies in both humans and animal models have shown the relevance of Th17 cells in early AD49, and are in agreement with our results showing an increase of plasma ASM activity in early AD patients resulted in infiltration of Th17 cells into the brain and an accelerated brain pathology. This evidence concerns the gene SMPD1 and Alzheimer disease.